Amanta Healthcare Limited IPO
Amanta Healthcare Limited was a mainboard IPO in the Pharmaceuticals sector, offered at ₹120–₹126 per share to raise ₹126 crore. The issue was subscribed 82.61× overall (QIBs 35.86×, NIIs 209.42×, retail 54.98×). It listed on 9 Sep 2025 at ₹135 and closed its first day at ₹142, a listing gain of +12.5% versus the ₹126 issue price. It now trades around ₹164 (+29.8% versus the issue price).
Frequently asked questions
- How many times was the Amanta Healthcare Limited IPO subscribed?
- The Amanta Healthcare Limited IPO was subscribed 82.61× overall — 35.86× in the QIB category, 209.42× among non-institutional investors, 54.98× in retail.
- What were the Amanta Healthcare Limited IPO listing gains?
- Amanta Healthcare Limited listed on 9 Sep 2025 at ₹135, closing its first day at ₹142 — a listing gain of +12.5% versus the ₹126 issue price.
- What were the retail allotment odds for the Amanta Healthcare Limited IPO?
- Retail was subscribed 54.98×, so a single-lot application had roughly a 1.8% chance of allotment (about 1 in 55), and allotment was finalised on 5 Sep 2025.
- What was the price band and lot size of the Amanta Healthcare Limited IPO?
- The price band was ₹120–₹126 per share, with a minimum lot of 119 shares (₹14,994 at the upper band).
- Who were the registrar and lead manager for the Amanta Healthcare Limited IPO?
- MUFG Intime India Private Limited (formerly Link intime India Private Limited) was the registrar, and Beeline Capital Advisors was the book-running lead manager.